Phase II Trial of Neoadjuvant[FEC100]/Cisplatin-Docetaxel ± Trastuzumab in Women With Over Expressed or Amplified Her2/Neu With Locally Advanced Breast Cancer
Clinical trial NCT00535509 · COMPLETED
Trial details
- NCT number
- NCT00535509
- Sponsor
- King Faisal Specialist Hospital & Research Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2013-06-01
- Enrollment
- 285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.